Your browser doesn't support javascript.
loading
Emerging role of non-coding RNAs in glucose metabolic reprogramming and chemoresistance in colorectal cancer.
Yan, Shushan; Wang, Shufeng; Wang, Xinyi; Dai, Wenqing; Chu, Jinjin; Cheng, Min; Guo, Zhiliang; Xu, Donghua.
Affiliation
  • Yan S; Department of Gastrointestinal and Anal Diseases Surgery of the Affiliated Hospital, Weifang Medical University, Weifang, China.
  • Wang S; Medical Experimental Training Center, Weifang Medical University, Weifang, China.
  • Wang X; Clinical Medicine of Basic Medical School, Shandong First Medical University, Jinan, China.
  • Dai W; Central Laboratory of the First Affiliated Hospital, Weifang Medical University, Weifang, China.
  • Chu J; Central Laboratory of the First Affiliated Hospital, Weifang Medical University, Weifang, China.
  • Cheng M; Department of Physiology, Weifang Medical University, Weifang, China.
  • Guo Z; Department of Spine Surgery, The 80th Group Army Hospital of Chinese People's Liberation Army (PLA), Weifang, China.
  • Xu D; Central Laboratory of the First Affiliated Hospital, Weifang Medical University, Weifang, China.
Front Oncol ; 12: 954329, 2022.
Article in En | MEDLINE | ID: mdl-35978828
ABSTRACT
Metabolic reprogramming plays a critical role in colorectal cancer (CRC). It contributes to CRC by shaping metabolic phenotypes and causing uncontrolled proliferation of CRC cells. Glucose metabolic reprogramming is common in carcinogenesis and cancer progression. Growing evidence has implicated the modifying effects of non-coding RNAs (ncRNAs) in glucose metabolic reprogramming and chemoresistance in CRC. In this review, we have summarized currently published studies investigating the role of ncRNAs in glucose metabolic alterations and chemoresistance in CRC. Elucidating the interplay between ncRNAs and glucose metabolic reprogramming provides insight into exploring novel biomarkers for the diagnosis and prognosis prediction of CRC.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: China